Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

Oct 27, 2010

Third Circuit Denies Mylan Motion for Interim Injunction

Oct 26, 2010

Mylan Reports Adjusted Diluted EPS of $0.43; Reaffirms 2010 Adjusted Diluted EPS Guidance of $1.55 - $1.65

Oct 22, 2010

Mylan and Mylan Charitable Foundation Award a Collective $1.25 Million to Prominent West Virginia Cultural Institutions

Oct 21, 2010

Mylan Receives Approval for Generic Version of Mirapex(R) Tablets

Oct 19, 2010

Mylan Declares Quarterly Preferred Stock Dividend

Oct 18, 2010

Mylan to Appeal Court Decision in Generic Paroxetine Hydrochloride CR Case

Oct 18, 2010

Mylan Schedules Third Quarter 2010 Financial Results Conference Call and Live Webcast

Oct 15, 2010

Mylan Receives Approvals for Generic Versions of Hyzaar(R) and Cozaar(R)

Oct 05, 2010

Mylan's Matrix Receives Tentative FDA Approval Under PEPFAR for Generic Version of Reyataz(R) Capsules HIV Treatment

Oct 04, 2010

Mylan Receives Approval for Fludarabine Phosphate Injection, USP

Pagination

First page
Previous page
…
Page 74
Page 75
Page 76
Page 77
Current page 78
Page 79
Page 80
Page 81
Page 82
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2024 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.